ArticleFrontiers in pharmacology2025
The clinical value of PLR, NLR, and MLR in predicting mortality risk in hospitalized patients.
Article in Frontiers in pharmacology, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
6 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Background: To analyze the trends and clinical significance of the platelet/lymphocyte ratio (PLR), neutrophil/lymphocyte ratio (NLR), and monocyte/lymphocyte ratio (MLR) in hospitalized patients prior to death. Method: A retrospective analysis was conducted on the PLR, NLR, and MLR of 341 hospitalized patients prior to death from January 2016 to October 2020 at Changzhou De'an Hospital, using inpatients with kidney disease and patients in rehabilitation as case-control groups, and hospital staff as a healthy control group, to statistically analyze relevant clinical data and test results. Results: Significant differences were observed in the PLR, NLR, and MLR prior to death in hospitalized patients compared to those with kidney disease, those in recovery, and the healthy control group ( Conclusion: The PLR, NLR, and MLR significantly associate with mortality risk in hospitalized patients, and could serve as important identification parameters for mortality.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.